Diaceutics PLC Diaceutics PLC -- Financial Calendar Update (1787A)
January 19 2024 - 2:00AM
UK Regulatory
TIDMDXRX
RNS Number : 1787A
Diaceutics PLC
19 January 2024
Diaceutics PLC - Financial Calendar Update
Belfast and London, 19 January 2024 - Diaceutics PLC (AIM: DXRX)
, a leading technology and solutions provider to pharma and biotech
companies, today announces the following financial calendar
events.
-- January 30, 2024 - Trading Update for the 12 months ended 31 December 2023
-- May 21, 2024 - Preliminary results for the full year ended 31 December 2023
-- June 24, 2024 - Annual General Meeting of shareholders
Enquiries:
Diaceutics PLC
Ryan Keeling, Chief Executive Officer Tel: +44 (0)28 9040 6500
Nick Roberts, Chief Financial Officer investorrelations@diaceutics.com
Stifel Nicolaus Europe Limited (Nomad Tel: +44 (0)20 7710 7600
& Broker)
Ben Maddison
Nick Harland
Kate Hanshaw
Alma Strategic Communications Tel: +44(0)20 3405 0205
Caroline Forde diaceutics@almastrategic.com
Matthew Young
Kinvara Verdon
About Diaceutics
At Diaceutics we believe that every patient should get the
opportunity to receive the right test and the right therapy to
positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with
an end-to-end commercialisation solution for precision medicines
through data analytics, scientific and advisory services enabled by
our platform DXRX - The Diagnostics Network(R)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCBBGDBCGBDGSI
(END) Dow Jones Newswires
January 19, 2024 02:00 ET (07:00 GMT)
Diaceutics (LSE:DXRX)
Historical Stock Chart
From May 2024 to Jun 2024
Diaceutics (LSE:DXRX)
Historical Stock Chart
From Jun 2023 to Jun 2024